Form 8-K - Current report:
SEC Accession No. 0001640334-25-001046
Filing Date
2025-06-13
Accepted
2025-06-13 17:10:52
Documents
18
Period of Report
2025-06-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 30512
2 CERTIFICATE artl_ex31.htm EX-3.1 1013
3 PRESS RELEASE artl_ex991.htm EX-99.1 7927
9 artl_ex31img1.jpg GRAPHIC 248019
10 artl_ex991img5.jpg GRAPHIC 3720
  Complete submission text file 0001640334-25-001046.txt   513993

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20250611.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250611_lab.xml EX-101.LAB 15735
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250611_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250611_pre.xml EX-101.PRE 9993
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250611_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4147
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 251047646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)